Medidata Solutions Performance
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Medidata Solutions are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Low | High |
Very Weak
Over the last 90 days Medidata Solutions has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Medidata Solutions is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
Fifty Two Week Low | 60.10 | |
Target High Price | 92.25 | |
Fifty Two Week High | 98.60 | |
Target Low Price | 77.00 |
Medidata |
Medidata Solutions Relative Risk vs. Return Landscape
If you would invest (100.00) in Medidata Solutions on December 29, 2023 and sell it today you would earn a total of 100.00 from holding Medidata Solutions or generate -100.0% return on investment over 90 days. Medidata Solutions is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Medidata, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
Medidata Solutions Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medidata Solutions' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Medidata Solutions, and traders can use it to determine the average amount a Medidata Solutions' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
MDSO |
Based on monthly moving average Medidata Solutions is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medidata Solutions by adding Medidata Solutions to a well-diversified portfolio.
Medidata Solutions Fundamentals Growth
Medidata Stock prices reflect investors' perceptions of the future prospects and financial health of Medidata Solutions, and Medidata Solutions fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medidata Stock performance.
Return On Equity | 10.86 | |||
Return On Asset | 7.55 | |||
Current Valuation | 5.54 B | |||
Shares Outstanding | 62.46 M | |||
Price To Earning | 128.08 X | |||
Price To Book | 8.39 X | |||
Price To Sales | 8.37 X | |||
Revenue | 684.56 M | |||
EBITDA | 38.94 M | |||
Cash Per Share | 0.72 X | |||
Debt To Equity | 30.10 % | |||
Cash Flow From Operations | 50.89 M | |||
Earnings Per Share | 0.72 X | |||
Total Asset | 684.18 M | |||
Retained Earnings | 265.33 M | |||
Current Asset | 383.2 M | |||
Things to note about Medidata Solutions performance evaluation
Checking the ongoing alerts about Medidata Solutions for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Medidata Solutions help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Medidata Solutions is not yet fully synchronised with the market data | |
Medidata Solutions has some characteristics of a very speculative penny stock | |
Medidata Solutions has a very high chance of going through financial distress in the upcoming years | |
Over 96.0% of the company shares are owned by institutional investors |
- Analyzing Medidata Solutions' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medidata Solutions' stock is overvalued or undervalued compared to its peers.
- Examining Medidata Solutions' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medidata Solutions' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medidata Solutions' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medidata Solutions' stock. These opinions can provide insight into Medidata Solutions' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Medidata Stock
If you are still planning to invest in Medidata Solutions check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medidata Solutions' history and understand the potential risks before investing.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |